نتایج جستجو برای: bipolar ii disorder bmd ii

تعداد نتایج: 1166286  

2018
Ru-Band Lu Yun-Hsuan Chang Tzu-Yun Wang Sheng-Yu Lee Po See Chen Yen Kuang Yang

Anxiety disorders (ADs), the most common comorbid illnesses with bipolar disorder (BP) has been reported to associate with dopamine system. Dopamine, metabolized to 3,4-dihydroxyphenylacetic acid (DOPAC) by aldehyde dehydrogenase 2 (ALDH2), and the distribution of the ALDH2*1/*1, and ALDH2*1/*2+ALDH*2/*2 alleles in the Han Chinese general population is relatively equal. The association between ...

Journal: :Archives of general psychiatry 2006
David Axelson Boris Birmaher Michael Strober Mary Kay Gill Sylvia Valeri Laurel Chiappetta Neal Ryan Henrietta Leonard Jeffrey Hunt Satish Iyengar Jeffrey Bridge Martin Keller

CONTEXT Children and adolescents who present with manic symptoms frequently do not meet the full DSM-IV criteria for bipolar I disorder (BP-I). OBJECTIVE To assess the clinical presentation and family history of children and adolescents with BP-I, bipolar II disorder (BP-II), and bipolar disorder not otherwise specified (BP-NOS). DESIGN Subjects and their primary caretaker were assessed by ...

Journal: :Journal of affective disorders 2007
E Vieta J Sánchez-Moreno A Bulbena L Chamorro J L Ramos J Artal F Pérez M A Oliveras J Valle J Lahuerta J Angst

BACKGROUND The detection and diagnosis of present or past hypomanic episodes is of key importance for the differential diagnosis between depressive disorders and type II bipolar disorder. However, there are few instruments available to satisfactorily screen for the latter condition. The Hypomania Symptom Checklist-32 (HCL-32) is a self-applied questionnaire with 32 hypomania items and 8 severit...

Journal: :The International Journal of Neuropsychopharmacology 2004

Journal: :The International Journal of Neuropsychopharmacology 2013

Journal: :Bipolar disorders 2008
Jonathan B Savitz Lize van der Merwe Dan J Stein Mark Solms Rajkumar S Ramesar

INTRODUCTION Impaired executive and memory function is a putative genetic trait marker of bipolar I disorder (BPD I). Although executive/memory function has been posited to be an endophenotype of BPD I, it is unclear whether this extends to bipolar spectrum illness. It is also unclear to what extent non-genetic factors such as childhood abuse, alcoholism and medication influence neurocognitive ...

Journal: :Neuropsychiatric Disease and Treatment 2006
Richard H Weisler

Carbamazepine (CBZ) has long been a therapeutic option for bipolar disorder. Carbamazepine extended-release capsules (CBZ-ERC) are a recent formulation of CBZ approved by the US Food and Drug Administration in 2004 for the treatment of acute manic and mixed episodes associated with bipolar I disorder. This new formulation was developed to improve dosing convenience and decrease daily fluctuatio...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید